Avian Influenza A (H5N1)

Avian influenza is an infection caused by avian (bird) influenza (flu) viruses. These influenza viruses occur naturally among birds. Wild birds worldwide carry the viruses in their intestines, but usually do not get sick from them. However, avian influenza is very contagious among birds and can make some domesticated birds, including chickens, ducks, and turkeys, very sick and kill them.

Infected birds shed influenza virus in their saliva, nasal secretions, and feces. Susceptible birds become infected when they have contact with contaminated secretions or excretions or with surfaces that are contaminated with secretions or excretions from infected birds. Domesticated birds may become infected with avian influenza virus through direct contact with infected waterfowl or other infected poultry, or through contact with surfaces (such as dirt or cages) or materials (such as water or feed) that have been contaminated with the virus.

Infection with avian influenza viruses in domestic poultry causes two main forms of disease that are distinguished by low and high extremes of virulence. The “low pathogenic” form may go undetected and usually causes only mild symptoms (such as ruffled feathers and a drop in egg production). However, the highly pathogenic form spreads more rapidly through flocks of poultry. This form may cause disease that affects multiple internal organs and has a mortality rate that can reach 90-100% often within 48 hours.

Assessment of Current Situation

The avian influenza A (H5N1) epizootic (animal outbreak) in Asia and parts of Europe, the Near East, and Africa is not expected to diminish significantly in the short term. It is likely that H5N1 infection among birds has become endemic in certain areas and that human infections resulting from direct contact with infected poultry will continue to occur. So far, the spread of H5N1 virus from person-to-person has been rare and has not continued beyond one person. No evidence for genetic reassortment between human and avian influenza A virus genes has been found; however, this epizootic continues to pose an important public health threat.

There is little pre-existing natural immunity to H5N1 infection in the human population. If these H5N1 viruses gain the ability for efficient and sustained transmission among humans, an influenza pandemic could result, with potentially high rates of illness and death. In addition, genetic sequencing of influenza A (H5N1) viruses from human cases in Vietnam and Thailand shows resistance to the antiviral medications amantadine and rimantadine, two of the medications commonly used for treatment of influenza. This would leave two remaining antiviral medications (oseltamivir and zanamivir) that should still be effective against currently circulating strains of H5N1 virus. Efforts to produce vaccine candidates that would be effective against avian influenza A (H5N1) viruses are under way. However, it will likely require many months before such vaccines could be mass produced and made widely available.

Research suggests that currently circulating strains of H5N1 viruses are becoming more capable of causing disease (pathogenic) in animals than were earlier H5N1 viruses. One study found that ducks infected with H5N1 virus are now shedding more virus for longer periods without showing symptoms of illness. This finding has implications for the role of ducks in transmitting disease to other birds and possibly to humans as well. Additionally, other findings have documented H5N1 infection among pigs in China and H5N1 infection in felines (experimental infection in housecats in the Netherlands and isolation of H5N1 viruses in tigers and leopards in Thailand).In addition, in early March 2006, Germany reported H5N1 infection in a stone marten (a weasel-like mammal). The avian influenza A (H5N1) virus that emerged in Asia in 2003 continues to evolve and may adapt so that other mammals may be susceptible to infection as well.

Notable findings of epidemiologic investigations of human H5N1 cases in Vietnam during 2005 have suggested transmission of H5N1 viruses to at least two persons through consumption of uncooked duck blood. One possible instance of limited person-to-person transmission of H5N1 virus in Thailand has been reported. This possibility is being further investigated in other clusters of cases in Vietnam and Indonesia.

The majority of known human H5N1 cases have begun with respiratory symptoms. However, one atypical fatal case of encephalitis in a child in southern Vietnam in 2004 was identified retrospectively as H5N1 influenza through testing of cerebrospinal fluid, fecal matter, and throat and serum samples. Further research is needed to ascertain the implications of such findings.

Human H5N1 Cases

Since January 2004, the World Health Organization (WHO) has reported human cases of avian influenza A (H5N1) in Asia, Africa, the Pacific, Europe, and the Near East. Cumulative number of confirmed human cases of avian influenza A/(H5N1) are available on the WHO Avian Influenza website.

The NanoMask

Protect Yourself and Your Family From

Hayfever * Smog * Toxic Fumes * Influenza * Whooping Cough * Anthrax * Biological Terrorism * SARS * Airborne Bacteria

The new NanoMask is the first mask in the world to utilize 2H Technology Plus™, a patented nanotechnology enhanced filter media that isolates and destroys viral and bacterial contaminants.

This enhanced filtration media has a .027 microns filtration capability. Tested to be 99.99% or greater effective against SARS, Avian Flu (H5N1), and other viruses. Nanoparticles absorb and destroy viruses and bacteria in both inhaled and exhaled breath.

The unique design, featuring a lower fit on the nose and a wide flange, provides an enhanced facial seal. The low profile does not interfere with eyewear.

Compact and lightweight, you'll want to rely on this brand new nanotechnology for enhanced protection during the upcoming flu season—and beyond.

Comfortable to wear, the two-piece face mask is adjustable and reusable. Simply dispose of the replacement filter. Adjustable head straps allow for a comfortable, personalized, secured fit and forms an effective seal against the face. This unique design and enhanced facial seal allows the NanoMask to overcome the most critical failing of typical N-95 masks.

The inner colored part is made of thermal plastic. The outer clear layer is made of PVC plastic. The filter is made of polyester material coated with nano particle.

Patented Filter Technology

2H Technology - Moisture Management. Why is it so important?

When a person with an infectious disease coughs, sneezes or speaks, bacterium and virus, encompassed by moisture, are released into the surrounding air. Infectious pathogens require moisture for reproduction and for transmission from person to person.

For this reason, managing the moisture output represents an essential aspect of infection control that must be considered in designing and developing devices for air filtration. This is especially true if the device will be in use over a prolonged period of time because moisture and particulates will eventually migrate through the filters that do not have the capacity to effectively retain moisture.

• Hypoallergenic
• Compact & lightweight
• Available in multiple colors
• Compatible with eyewear
• Filters replaced quickly and easily
•Tested and proven effective